The core activity of diagene GmbH encompasses the provision of comprehensive molecular and pharmacogenomic services as well as genetic testing to improve patient care. This includes, in particular:
* Genetic testing and diagnostics, including the diagnosis of hereditary disorders and genetic predisposition to certain diseases such as cardiovascular, neurodegenerative or metabolic disorders
* Clinical research projects, including Phase 2 to Phase 4 studies
* Statistical analysis of research results, including multivariate modeling and epidemiological approaches
* Organization of large-scale multicenter scientific studies
* Operation of a reference laboratory for complex genetic and molecular analyses
In addition, the company also offers services in the areas of routine laboratory testing, clinical chemistry, and diagnosis and treatment of metabolic disorders.